logo

Aurinia Pharmaceuticals Inc. (AUP.V)



Trade AUP.V now with
  Date
  Headline
9/25/2018 4:14:45 PM Urinia Completes Enrollment Of AURORA, Its Phase 3 Clinical Trial For The Treatment Of Lupus Nephritis
6/25/2018 7:03:16 AM Aurinia Pharma Says First Lupus Nephritis Patients Roll Over Into AURORA 2 Extension Study; Begins Phase II FSGS Trial
2/8/2018 6:14:48 AM RBC Capital Markets Starts Aurinia Pharmaceuticals Inc. (AUPH) At Outperform With $9 Price Target